Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 368 participants.
Also called NCT02722265
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 368 participants
- Sponsor
- Registry
-
NCT02722265
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02722265. Allocation not applicable; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2017-07-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension
- Condition
- Essential Hypertension
- Intervention (Drug)
- CS-3150
- Lead sponsor
- Daiichi Sankyo Co., Ltd.
Record details
- Record id
cardio:ct-nct02722265- Content hash
c015fa2fc7249a8c16d407b2bcbf39a0e497926c9e4bbd471ef71165e4842c46